Concourse Financial Group Securities, Inc. Aim Immuno Tech Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$0.35 - $0.61 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$0.33 - $0.48 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$0.4 - $0.56 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$0.44 - $0.71 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	SELL	$0.44 - $0.71 $220 - $355	-500 Closed	0 $0
Q4 2022 Jan 30, 2023	BUY	$0.31 - $0.6 $155 - $300	500 New	500 $0
Q3 2022 Nov 15, 2022	SELL	$0.57 - $0.81 $285 - $405	-500 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.93 - $2.39 $965 - $1,195	500 New	500 $1,000
Q1 2021 May 13, 2021	BUY	$1.88 - $2.82 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$1.68 - $2.45 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.77 - $3.88 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.9 - $2.94 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$0.56 - $6.1 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.39 - $0.71 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$0.71 - $4.42 $0 - $0	0 New	0 $0

Others Institutions Holding AIM

# of Institutions

Shares Held

8.44M

Call Options Held

Put Options Held

Armistice Capital, LLC New York, NY

4.08M
Shares

$1.26 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.99M
Shares

$616,498
0.0% of portfolio
Black Rock Inc. New York, NY

698K
Shares

$216,462
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

401K
Shares

$124,318
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

229K
Shares

$70,930
0.0% of portfolio

View Full List

About AIM ImmunoTech Inc.

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $14.9M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

More about AIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account